Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression

Francis S. Markland , Radu Minea , Fritz Costa , Stephen Swenson
Molecular Cancer Therapeutics 3 ( 4) 499 -511

89
2004
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

Georg Lurje , Yan Ning , Susan Groshen , Cosima Lenz
Journal of gastrointestinal oncology 2 ( 2) 77 -84

112
2011
Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study)

Pierre Bohanes , Georg Lurje , Yan Ning , Ellen Hollywood
Anticancer Research 30 ( 10) 4209 -4217

31
2010
A Meta-Analysis of Soyfoods and Risk of Stomach Cancer: The Problem of Potential Confounders

Malcolm C. Pike , Anna H. Wu , Dongyun Yang
Cancer Epidemiology, Biomarkers & Prevention 9 ( 10) 1051 -1058

67
2000
Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study

Tim Kristedja , Susan Groshen , Steven J. O'Day , Robert Milford
Clinical Cancer Research 11 ( 3) 1237 -1246

71
2005
Generation of a concise gene panel for outcome prediction in urinary bladder cancer

Susan Groshen , Anirban Mitra , Richard Cote , Dongyun Yang
Molecular Cancer Therapeutics 6

2007
Outcomes of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Adults with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

Monzr M. Al Malki , Vinod Pullarkat , Patricia Aoun , Samer K. Khaled
Transplantation and Cellular Therapy 27 ( 3)

2021
Cytokine Gene Polymorphisms are Associated with Response to Blinatumomab in B Cell Acute Lymphoblastic Leukemia.

Ketevan Gendzekhadze , Ibrahim Aldoss , Vinod A Pullarkat , Samer Khaled
European Journal of Haematology 106 ( 6) 851 -858

2021
Effect of JAK2 SNP rs2274472 on outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial.

Martin D. Berger , Sebastian Stintzing , Volker Heinemann , Dongyun Yang
Journal of Clinical Oncology 35 595 -595

2017
Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer.

Mitsukuni Suenaga , Marta Schirripa , Shu Cao , Wu Zhang
Journal of Clinical Oncology 35 596 -596

1
2017
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study

Ravit Geva , Loredana Vecchione , Konstantinos T Kalogeras , Benny Vittrup Jensen
Gut 64 ( 6) 921 -928

25
2015
Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer

Sebastian Stintzing , Wu Zhang , Volker Heinemann , Daniel Neureiter
Molecular Cancer Therapeutics 14 ( 10) 2374 -2381

4
2015
18
2015
TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy

Satoshi Matsusaka , Wu Zhang , Shu Cao , Diana L. Hanna
Molecular Cancer Therapeutics 15 ( 6) 1405 -1411

6
2016
Clinical significance of TLR1 I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab

Satoshi Okazaki , Fotios Loupakis , Sebastian Stintzing , Shu Cao
Molecular Cancer Therapeutics 15 ( 7) 1740 -1745

6
2016